Manchester Management Accuses Vermillion of Changing Meeting Date to Discourage Shareholder Action | GenomeWeb

One of Vermillion's largest shareholders this week accused the firm's board of directors of shifting forward its annual meeting in order to discourage shareholder action aimed at replacing members of Vermillion's board and management team.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.